Keywords: 1st, approval, r-pr, noven, menorest, regulatory, authorities
1st Approval For R-PR, Noven's Menorest
Article | 14 November 1994
The regulatory authorities in the Netherlands have granted approval for a transdermal estradiol patch, Menorest, developed by Rhone-Poulenc Rorer and ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
